Literature DB >> 12598042

Interaction of antimicrobial peptides from Australian amphibians with lipid membranes.

Isabelle Marcotte1, Kate L Wegener, Yuen-Han Lam, Brian C S Chia, Maurits R R de Planque, John H Bowie, Michèle Auger, Frances Separovic.   

Abstract

Solid-state NMR and CD spectroscopy were used to study the effect of antimicrobial peptides (aurein 1.2, citropin 1.1, maculatin 1.1 and caerin 1.1) from Australian tree frogs on phospholipid membranes. 31P NMR results revealed some effect on the phospholipid headgroups when the peptides interact with DMPC/DHPC (dimyristoylphosphatidylcholine/dihexanoylphosphatidylcholine) bicelles and aligned DMPC multilayers. 2H NMR showed a small effect of the peptides on the acyl chains of DMPC in bicelles or aligned multilayers, suggesting interaction with the membrane surface for the shorter peptides and partial insertion for the longer peptides. 15N NMR of selectively labelled peptides in aligned membranes and oriented CD spectra indicated an alpha-helical conformation with helix long axis approximately 50 degrees to the bilayer surface at high peptide concentrations. The peptides did not appear to insert deeply into PC membranes, which may explain why these positively charged peptides preferentially lyse bacterial rather than eucaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598042     DOI: 10.1016/s0009-3084(02)00182-2

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  42 in total

1.  APD: the Antimicrobial Peptide Database.

Authors:  Zhe Wang; Guangshun Wang
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs.

Authors:  Yeang-Ling Pan; John T-J Cheng; John Hale; Jinhe Pan; Robert E W Hancock; Suzana K Straus
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

3.  Insights on the interactions of synthetic amphipathic peptides with model membranes as revealed by 31P and 2H solid-state NMR and infrared spectroscopies.

Authors:  Marise Ouellet; Geneviève Bernard; Normand Voyer; Michèle Auger
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

Review 4.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

5.  Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2.

Authors:  John T J Cheng; John D Hale; Jason Kindrachuk; Håvard Jenssen; Havard Jessen; Melissa Elliott; Robert E W Hancock; Suzana K Straus
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

6.  Oriented samples: a tool for determining the membrane topology and the mechanism of action of cationic antimicrobial peptides by solid-state NMR.

Authors:  Matthieu Fillion; Michèle Auger
Journal:  Biophys Rev       Date:  2015-02-24

Review 7.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

8.  Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization.

Authors:  A James Mason; Arnaud Marquette; Burkhard Bechinger
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

Review 9.  High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

Authors:  Guangshun Wang; Biswajit Mishra; Raquel F Epand; Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2014-01-23

10.  A theoretical analysis of secondary structural characteristics of anticancer peptides.

Authors:  Sarah R Dennison; Frederick Harris; Tailap Bhatt; Jaipaul Singh; David A Phoenix
Journal:  Mol Cell Biochem       Date:  2009-07-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.